Increase in the expression of biglycan mRNA expression co-localized closely with that of type I collagen mRNA in the infarct zone after experimentally-induced myocardial infarction in rats

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 9, 1998, Pages 1749-1756

  Yamamoto, Keizo ^a   Kusachi, Shozo ^a   Ninomiya, Yoshifumi ^a   Murakami, Masahiro ^a   Doi, Masayuki ^a   Takeda, Kenji ^a   Shinji, Toshiyuki ^a   Higashi, Toshihiro ^a   Koide, Norio ^a   Tsuji, Takao ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Extracellular matrix; Infarct healing; Molecular biology; Proteoglycan

Indexed keywords

BIGLYCAN; COLLAGEN TYPE 1; MESSENGER RNA;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRANULATION TISSUE; IN SITU HYBRIDIZATION; LEFT CORONARY ARTERY; MALE; MESENCHYME CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 18844471149     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0737     Document Type: Article

References (34)

1. BREUER B, SCHMIDT G, KRESSE H, 1990. Non-uniform influence of transforming growth factor-beta on the biosynthesis of different forms of small chondroitin sulphate/dermatan sulphate proteoglycan. Biochem J 269: 551-554.
2. 1 in normal heart and in myocardial infarction. Ann NY Acad Sci 593: 148-160.
3. CHURCH GM, GILBERT W, 1984. Genomic sequencing. Proc National Acad Sci USA 81: 1991-1995.
4. DREHER KL, ASUNDI V, MATZURA D, COWAN K, 1990. Vascular smooth muscle biglycan represents a highly conserved proteoglycan within the arterial wall. Eur J Cell Biol 53: 296-304.
5. FALKENHAHN M, FRANKE F, BOHLE RM, ZHU Y, STAUSS HM, BACHMANN S, DANILOV S, UNGER T, 1995. Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 25: 219-226.
6. FEINBERG AP, VOGELSTEIN B, 1984. A technique for radio-labeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 137: 266-267.
7. FISHBEIN MC, MACLEAN D, MAROKO PR, 1978. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90: 57-70.
8. FISHER LW, TERMINE JD, YOUNG MF, 1989. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with protoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264: 4571-4576.
9. GENOVESE C, ROWE D, KREAM B, 1984. Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochem 23: 6210-6216.
10. KRESSE H, HAUSSER H, SCHÖNHERR E, BITTNER K, 1994. Biosynthesis and interactions of small chondroitin/ dermatan sulphate proteoglycans. Eur J Clin Chem Clin Biochem 32: 259-264.
11. KRULL NB, ZIMMERMANN T, GRESSNER AM, 1993. Spatial and temporal patterns of gene expression for the proteoglycans biglycan and decorin and for transforming growth factor-beta 1 revealed by in situ hybridization during experimentally induced liver flbrosis in the rat. Hepatology 18: 581-589.
12. KRUSIUS T, RUOSLAHTI E, 1986. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci USA 83: 7683-7687.
13. LASER A, NEUBAUER S, TIAN R, HU K, GAUDRON P, INGWALL JS, ERTL G. 1996. Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction. J Am Coll Cardiol 27: 487-493.
14. MEYER DH, KRULL N, DREHER KL, GRESSNER AM, 1992. Biglycan and decorin gene expression in normal and fibrotic rat liver: cellular localization and regulatory factors. Hepatology 16: 204-216.
15. NAKATSUKASA H, NAGY P, EVARTS RP, HSIA CC, MARSDEN E, THORGEIRSSON SS, 1990. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III and IV transcripts in carbon tetrachloride-induced rat liver flbrosis. J Clin Invest 85: 1833-1843.
16. OKA T, KOIDE N, SHINJI T, TAKAYAMA N, SASAKI S, UJIKE K, NAKAMURA M, HIRASAKI S, TSUJI T, 1997. Transient appearance of perisinusoidal chondroitin sulfate proteoglycans associated with enhanced expression of biglycan gene during D-galactosamine-induced acute liver injury in rats. Hepatology Research 8: 164-172.
17. OLDBERG A, ANTONSSON P, LINDBLOM K, HEINEGARD D, 1989. A collagen-binding 59-kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG-S1 and PG-S2 (decorin). EMBO J 8: 2601-2604.
18. PERRYMAN MB, YU QT, MARIAN AJ, MARES A JR, CZERNUSZEWICZ G, IFEGWU J, HILL R, ROBERTS R, 1992. Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy. J Clin Invest 90: 271-277.
19. PFEFFER MA, BRAUNWALD E, 1990. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172.
20. POGÁNY G, HERNANDEZ DJ, VOGEL KG, 1994. The in vitro interaction of proteoglycans with type I collagen is modulated by phosphate. Arch Biochem Biophys 313: 102-111.
21. RIESSEN R, ISNER JM, BLESSING E, LOUSHIN C, NIKOL S, WIGHT TN, 1994. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 144: 963-974.
22. RUOSLAHTI E, YAMAGUCHI Y, 1991. Proteoglycans as modulators of growth factor activities. Cell 64: 867-869.
23. SCHÖNHERR E, WITSCH-PREHM P, HARRACH B, ROBENEK H, RAUTERBERG J, KRESSE H, 1995. Interaction of biglycan with type I collagen. J Biol Chem 270: 2776-2783.
24. SCOTT JE, 1988. Proteoglycan-flbrillar collagen interactions. Biochem J 252: 313-323.
25. SCOTT PG, DODD CM, TREDGET EE, GHAHARY A, RAHEMTULLA F, 1995. Immunohistochemical localization of the proteoglycans decorin, biglycans and versican and transforming growth factor-beta in human post-burn hypertrophic and mature scars. Histopathol 26: 423-431.
26. SELYE H, BAJUSZ E, GRASSO S, MENDELL P, 1960. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology : 398-407.
27. SPORN MB, ROBERTS AB, 190. TGF-β: problems and prospects. Cell Regulat 1: 875-882.
28. SUN Y, WEBER KT, 1996. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res 31: 518-525.
29. TAN EM, HOFFREN J, ROUDA S, GREENBAUM S, FOX JW IV, MOORE JH JR, DODGE GR, 1993. Decorin, versican, and biglycan gene expression by keloid and normal dermal flbroblasts: differential regulation by basic fibroblast growth factor. Exp Cell Res 209: 200-207.
30. WEISMAN HF, HEALY B, 1987. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovas Dis 30: 73-110.
31. WESTERGREN-THORSSON G, HERNNAS J, SARNSTRAND B, OLDBERG A, HEINEGARD D, MALMSTROM A, 1993. Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary flbrosis in rats. J Clin Invest 92: 632-637.
32. WHITE HD, NORRIS RM, BROWN MA, BRANDT PW, WHITLOCK RM, WILD CJ, 1987. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76: 44-51.
33. YAMAGUCHI Y, RUOSLAHTI E, 1988. Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation. Nature 336: 244-246.
34. YAMAGUCHI Y, MANN DM, RUOSLAHTI E, 1990. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346: 281-284.